• Biotinylated Human B7-H6 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
  • The purity of Biotinylated Human B7-H6 is greater than 95% as determined by SEC-HPLC.
  • Human NKp30, hFc Tag captured on CM5 Chip via Protein A can bind Biotinylated Human B7-H6, His-Avi Tag with an affinity constant of 0. 227 Mu M as determined in SPR assay (Biacore T200).

Human B7-H6 protein (Recombinant) (C-His-Avi) {Biotin} (STJP001558)

SKU:
STJP001558

Shipping:
Free Shipping
Current Stock:
Host: HEK293
Note: STRICTLY FOR FURTHER RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Recombinant-Human B7-H6-C-His-Avi protein was developed from hek293 and has a target region of C-His-Avi. For use in research applications.
Conjugation: Biotin
Formulation: Lyophilised from 0.2 µm filtered PBS solution pH7.4.
Dilution Range: Upon receipt centrifuge vial to ensure maximal product extraction, recommended: 20sec, 5K RPM
Storage Instruction: The lyophilized protein is stable for at least 1 year from date of receipt at-20°C.
Endotoxin: Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg (1EU/µg).
Gene Symbol: NCR3LG1
Gene ID: 374383
Uniprot ID: NR3L1_HUMAN
Immunogen Region: Asp25-Ser262
Immunogen: DNA sequence encoding Human B7-H6 including a C-His-Avi tag was expressed in HEK293 Cells. The recombinant protein was then biotinylated site specific using the AVItag biotinylation technology.
Function Triggers NCR3-dependent natural killer cell activation.
Protein Name Natural Cytotoxicity Triggering Receptor 3 Ligand 1
B7 Homolog 6
B7-H6
Database Links Reactome: R-HSA-198933
Cellular Localisation Cell Membrane
Single-Pass Type I Membrane Protein
Alternative Protein Names Natural Cytotoxicity Triggering Receptor 3 Ligand 1 protein
B7 Homolog 6 protein
B7-H6 protein
NCR3LG1 protein
B7H6 protein

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance